hahhaa yep buddy! Hilarious that any serious OTC player would ever take the time to attempt to knock private placement funding that resulted in phase III human clinical trials being initiated.
Just imagine if CEO Dixon utilized in any typical OTC financing instrument other than a PPM, which all experienced penny playing vets know is the friendliest form of OTC financing instrument out there:)
News 
Market Data 
Discover 
